Literature DB >> 3171614

Spontaneous subarachnoid haemorrhage: expert system for appraisal of the prognosis and computer-supported decision for therapy.

K Spitzer1, A Thie, K Kunze.   

Abstract

An expert system is presented which allows appraisal of the prognosis and a computer-supported decision for the therapy of patients with acute spontaneous subarachnoid haemorrhage (SAH). The knowledge of physicians as a synthesis of their own and other clinicians' experience is simulated with methods of artificial intelligence by setting up two data banks. In one data bank, selected information on the correlation between initial clinical parameters, on the one hand, and mortality, outcome and complications, on the other, from about 250 neurological publications is stored, taking into consideration the therapeutic regimens applied. A second data bank receives clinical and laboratory data profiles of a patient population which has already been treated. The expert system is able to compare the individual initial findings with the corresponding parameter combination stored in the data banks regarding the decision for therapy of a patient to be treated. This enables both calculation of the probable complications and prediction of the expected outcome in relation to various possible forms of therapy. The expert system can thus indicate the kind of therapy where the lowest number of complications and the best outcome can be expected, thus supporting the decision of the physician. As each new patient is treated, the volume of stored information increases, so the system possesses self-learning characteristics. To check the validity of the prognoses, the outcome estimated by the expert system for 51 patients with spontaneous SAH was compared with the actual outcome, and a high level of agreement was attained.

Entities:  

Mesh:

Year:  1988        PMID: 3171614     DOI: 10.1007/bf00314228

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  56 in total

1.  A modular self-describing clinical databank system.

Authors:  S Weyl; J Fries; G Wiederhold; F Germano
Journal:  Comput Biomed Res       Date:  1975-06

2.  The blood leucocyte count and its prognostic significance in subarachnoid haemorrhage.

Authors:  G Neil-Dwyer; J Cruickshank
Journal:  Brain       Date:  1974-03       Impact factor: 13.501

3.  Surgical risk as related to time of intervention in the repair of intracranial aneurysms.

Authors:  W E Hunt; R M Hess
Journal:  J Neurosurg       Date:  1968-01       Impact factor: 5.115

4.  Arteriovenous anomalies of the brain. Fate of patients not having definitive surgery.

Authors:  H J Svien; J A McRae
Journal:  J Neurosurg       Date:  1965-07       Impact factor: 5.115

5.  Artificial intelligence in medicine. Where do we stand?

Authors:  W B Schwartz; R S Patil; P Szolovits
Journal:  N Engl J Med       Date:  1987-03-12       Impact factor: 91.245

6.  Timing of aneurysm surgery.

Authors:  N F Kassell; C G Drake
Journal:  Neurosurgery       Date:  1982-04       Impact factor: 4.654

7.  Ventricular dilatation and communicating hydrocephalus following spontaneous subarachnoid hemorrhage.

Authors:  J Vassilouthis; A E Richardson
Journal:  J Neurosurg       Date:  1979-09       Impact factor: 5.115

8.  Subarachnoid hemorrhage from intracranial aneurysms. Surgical management and natural history of disease.

Authors:  T M Sundt; J P Whisnant
Journal:  N Engl J Med       Date:  1978-07-20       Impact factor: 91.245

9.  Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage.

Authors:  G S Allen; H S Ahn; T J Preziosi; R Battye; S C Boone; S C Boone; S N Chou; D L Kelly; B K Weir; R A Crabbe; P J Lavik; S B Rosenbloom; F C Dorsey; C R Ingram; D E Mellits; L A Bertsch; D P Boisvert; M B Hundley; R K Johnson; J A Strom; C R Transou
Journal:  N Engl J Med       Date:  1983-03-17       Impact factor: 91.245

10.  Long-term prognosis in surgically treated intracranial aneurysms. Part 1: Mortality.

Authors:  L Artiola i Fortuny; L Prieto-Valiente
Journal:  J Neurosurg       Date:  1981-01       Impact factor: 5.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.